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Summary A new cell line, XH1, has been derived from an invasive focally keratinising adenosquamous
carcinoma of the cervix in a 32 year old patient. It has been maintained in long term monolayer culture for 26
months, and passaged over 100 times (>> 300 population doublings). It is aneuploid with a mean
chromosome number of 78. Examination using two minisatellite hypervariable DNA probes has shown it to be
different from other cell lines maintained in this laboratory and from HeLa. Two sublines, XH1a and XHlb,
show marked differences in monolayer culture, growth in soft agar, and xenograft formation. XH1 and XH1a
cells readily form subcutaneous xenografts, and lung colonies can be established by their intravenous injection.
Subcutaneous injection of XHlb cells results in rapid cell growth for a few days after which the tumour
undergoes degeneration and then regresses completely. The XH1 karyotype has many rearranged chromo-
somes. Parental XH1 cells and both sublines show integration of HPV16 into the genome.
In England and Wales 4% of cancer deaths are due to
carcinoma of the cervix. There are approximately 4,000 new
cases of invasive cervical carcinoma per annum, with an
overall mortality of 50% (OPCS, 1990a). Whilst the total
number of deaths has fallen slightly, there has been a signi-
ficant increase in cervical cancer incidence and mortality in
women under the age of 45. In 1974-1978 there were 692
deaths from cervical cancer in these younger women. In the
next 5 years, 1979-1983, the number had increased to 986,
with 1,203 deaths 1984-1988 (OPCS, 1977-1990b). During
the same period deaths in older women fell from 9,607 in
1974-1978 to 8,595 in 1979-1984 to 7,860 in 1984-1988
(OPCS, 1977-1990b). A similar trend has been reported from
elsewhere. In Australia, for example, the proportion of
women under 35 with cervical cancer increased from under
9% of cases in the 1950's, to 25% in the 1970's and 1980's
(Elliott et al., 1989).
Squamous carcinoma is the commonest carcinoma of the
cervix (Anderson, 1985), although if mucin stains are used,
up to 30% are shown to be adenosquamous (Buckley & Fox,
1989). In most cases there appears to be a progression from
mild cervical intra-epithelial neoplasia (CIN 1), through
moderate (CIN 2), to severe dysplasia/carcinoma-in situ (CIN
3) before frank invasive carcinoma supervenes (Reagan et al.,
1953; Richart, 1967; Buckley et al., 1982). In a small number
of women, the diagnosis of invasive tumour is made soon
after a previous negative smear, with no detectable transition
stage (Ashley, 1966; Hakama & Penttinen, 1981; Peters et al.,
1988). The cytological characteristics of the cells involved in
CIN 3 as well as those in invasive carcinoma are those of a
malignant phenotype, and show pleomorphism, loss of polar-
ity, abnormal mitotic figures and aneuploidy. The cells of
invasive carcinoma have the ability to transgress the base-
ment membrane, spread locally and metastasise, with a re-
sulting 50% mortality (OPCS, 1990b). The cells of in situ
carcinoma have not transgressed the basement membrane
and may lack factors that would enable them to do so.
In order to study differences between normal, dysplastic
and invasive malignant cervical epithelial cells we have estab-
lished such cells in monolayer culture and as xenografts in
nude mice. In this paper we report on a new cervical car-
cinoma cell line XH1, established during the course of this
study, and on the cultural and xenograft behaviour of the
two sublines, XHla and XHlb, derived from it.
Materials and methods
Initiation oflong term culture ofXHI
The XHI cell line was established from a Wertheim's hyster-
ectomy specimen of an adenosquamous carcinoma in a 32
year old patient. The tumour consisted mainly of moderately
differentiated focally keratinising squamous carcinoma, with
clear cell areas and foci of glandular differentiation contain-
ing PAS positive-diastase resistant mucin. Occasional multi-
nucleate giant tumour cells were seen.
Minor modifications of methods previously published were
used to establish the cell line (Stanley & Parkinson, 1979;
Stanley & Dahlenburg, 1984). Portions of the tumour were
minced and incubated in protease (Sigma Chemical Co,
Dorset), collagenase (Lorne Diagnostics Ltd, Suffolk) and
DNAase (Sigma ) in EBSS (Earle's Balanced Salt Solution)
containing 100IU penicillinml-l and 100jgml-' strepto-
mycin (Gibco BRL Ltd, Middx). Single cells and small
clumps were seeded into flasks containing Mitomycin-C
treated Swiss albino embryonic mouse fibroblast 3T3 cells
(ATCC CCL92) (ICN Flow Laboratories Ltd, Bucks). An
enriched medium was used consisting of DMEM (Dulbecco's
Modification of Eagle's Medium) (ICN Flow) with 20%
FCS, 2 mM L-glutamine, antibiotics, 0.4fig ml1 hydrocor-
tisone (Glaxo Laboratories Ltd, Middx), 10jigml-l bovine
insulin (Sigma), 10ngml-' epidermal growth factor (ICN
Flow), and 10 ng ml' cholera toxin (Sigma).
At passage #4 a colony consisting predominantly of small
rapidly dividing epithelial cells was selected and passaged
further. Fibroblasts from the cervical stroma were removed
by incubation with 0.02% EDTA in EBSS at 37°C for
2-3 min and then vigorous pipetting against the surface of
the flask (Stanley & Parkinson, 1979). The 3T3 feeder layer
was omitted from passage #6 onwards (>>300 population
doublings).
A Mycotect kit (Gibco) was used to test for Mycoplasma
infection at 3-4 week intervals.
XHJa and XHlb sublines
At passage #29 XH1 single cells were plated in enriched
medium at densities of 5-100 cells/well in 24-well plates on
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Mitomycin-C treated 3T3 cells. Growth was only seen in
wells seeded with 50-100 cells/well. After passage #4, 3T3
feeder cells were no longer required. Two sublines of cells
emerged with differing cell morphologies (see Results). One
of each type was selected, designated XHla and XHlb. They
were subjected to more than 80 further passages.
Karyotyping
Chromosome preparations from XHI cells passage #6 were
made by standard methods using colcemid for 1-2 h at
a final concentration of 0.02p1gmlm' and hypotonic KCI/
EDTA for 20 min (Seizinger et al., 1987). Chromosomes
from 30 metaphases were counted on aceto-orcein stained
slides, and 13 cells from G-banded preparations were ana-
lysed in full from photographs.
Hypervariable minisatellite DNA probing
Locus-specific hypervariable minisatellite probes, MS1 and
MS31 (ICI Biological Products, Cheshire) (Wong et al.,
1987; 1988) were used to ensure that the XH1 cells were
not contaminated with the established cell lines Caski
(Patillo et al., 1977), A431 (Giard et al., 1973) and Bowes
melanoma (Rifkin et al., 1974), also maintained in this
laboratory.
DNA was isolated from the patient's blood and cultured
cells by proteinase K (50 mg ml) (Boehringer Corporation
London Ltd, BCL, Sussex) and phenol-chloroform extraction
(Sambrook et al., 1989). Ten jig DNA was digested with
HinJI (BCL) and electrophoresed in a 0.7% agarose gel until
fragments smaller than 2 kb had run off the gel. After elec-
trophoresis, the DNA fragments were denatured, transferred
to Hybond-N (Amersham International plc, Bucks), and
hybridised with MS31 labelled with digoxigenin by random
hexanucleotide priming, according to the manufacturer's
instructions (BCL) (Feinberg & Vogelstein, 1983). Though
HeLa cells (Gey et al., 1952) have not been grown in this
laboratory, HeLa DNA (obtained from Dr Farrell, Ludwig
Institute, London) was also probed to exclude contamination
of the other cell lines with HeLa. Because the bands obtained
using A431 and Caski ran in a similar position, DNA from
these cell lines and from XH1 and Bowes melanoma was also
probed with digoxigenin-labelled MS1.
DNA preparationfor HPV analysis
Total cellular DNA was purified by lysing the cells in 10 mM
Tris-Cl (pH 8) - 10 mM NaCl - 10 mM EDTA (pH 8) - 0.5%
SDS containing 100pgml-' proteinase K and incubation
overnight at 37°C. Proteins were removed by sequential
extractions with equal volumes of phenol, phenol-chloro-
form-isoamyl alcohol (25:24:1) and chloroform-isoamyl alco-
hol (24:1). RNA was then removed by treatment with 501ag
ml-' RNAase A, followed by digestion with 100 lgml-'
proteinase K in 1% SDS and deproteination as above. DNA
was precipitated with ethanol, resuspended in water and the
concentration determined by spectrophotometry.
PCR
DNA amplification was performed using the degenerate
primers MY09 (5'-CGTCC[A/C]A[A/G][A/G]GGA[A/T]ACT
GATC-3') and MYll (5'-GC[A/C]CAGGG[A/T]CATAA[C/
T]AATGG-3') (Perkin-Elmer Cetus, ILS, London). These
amplify an approximately 450bp region located in the LI
open reading frame of all sequenced papillomaviruses. PCR
reactions were performed in a volume of 100 in 10mM
Tris-Cl (pH 8.3) - 2.5 mM MgCI2 - 50 mM KCI with deoxyri-
bonucleotides at final concentrations of 200 ILM each, primers
at 1I1M and target DNA at Lgml-'. 2.5 U of Taq DNA
polymerase (Perkin-Elmer Cetus) were added to this mixture
and the whole overlaid with 100 lI mineral oil. The ampli-
fication mixture was incubated first at 94°C for 5 min then
for 30 cycles of 94°C for 30 s, 50°C for 30 s and 72°C for 45 s
each. Extension was completed by a final incubation at 72°C
for 5 min.
Aliquots (one-tenth) of the amplification mixture were
precipitated with ethanol, and each digested with BamHI,
EcoRI, HaeIII, HincII or PstI, and then analysed on 4%
NuSieve-1% SeaKem agarose gels (FMC Products, Flowgen,
Kent).
Human placental DNA was used as a negative control to
confirm the absence of false positives in the PCR reactions.
Hybridisation analysis
Total cellular DNA in 10 lg aliquots either undigested or
each digested with BamHI, HindIII or PstI, were each
electrophoresed through 0.8% agarose gels in TAE buffer.
After electrophoresis DNA samples were prepared and trans-
ferred to nylon membranes (HyBond-N, Amersham, Bucks)
using a Posiblotter (Stratagene, NBL, Northumberland)
under the conditions described by the manufacturers. A ran-
dom primer labelling technique (MultiPrime, Amersham) was
used to generate 32P-labelled HPV16 probes. These probes
were used to challenge membrane bound DNA samples in
5 x SSC - 5 x Denhardts - 0.5% SDS - 100 gml-'
denatured, sheared salmon sperm DNA at (Tm-20'C) for
16 h. They were washed first at low stringency (Tm.40TC) then
at high stringency (Tm-IO0C). Kilobase ladder DNA markers
(BRL, Paisley) were used to determine the size of the PGR
product.
Culture in soft agar
XHIa or XHlb cells were mixed with 0.5% agar solution
(Agar Noble, Difco Laboratories, Surrey) in enriched
medium to give a final agar concentration of 0.35%, and a
cell density 5 x I04ml-'. After 4 weeks the agar was
decanted and colonies containing more than 50 cells were
counted.
Xenografts
Xenograft production was attempted in 53 nude mice (athy-
mic nu/nu on Balb/c background). Twelve were female, 41
were male and they ranged in age from 3-20 weeks. Single
cell suspensions in PBS pH 7.2 of various passages of XH1,
XHIa, XHlb cells, and a xenograft obtained by inoculation
of passage #5 of XH1 cells, were used. Five x 106 cells were
injected subcutaneously into both pectoral regions of 43
mice, and 107 cells were also injected intraperitoneally into
three of these mice. 1-5 x I04 cells were injected into the tail
vein of 22 mice, 12 of which also had simultaneous bilateral
subcutaneous inoculation. Eight mice died immediately after
intravenous injection, and four more died unexpectedly. Mice
bearing XH1 or XH1a xenografts were sacrificed either when
the subcutaneous tumours reached 1.5-2 cm in maximum
diameter, or seemed about to ulcerate. Mice bearing XH1b
xenografts were sacrificed at 5 and 7 days and thereafter at
weekly intervals up to 50 days.
Immunocytochemistry
Formalin-fixed paraffin-embedded sections of the primary
tumour, pellets of XHI, XHIa and XHlb cells (Heyderman
et al., 1989), and sections of xenografts were stained with a
variety of antibodies. Monoclonal antibodies to epithelial
membrane antigen (EMA) (Heyderman et al., 1979), carcino-
embryonic antigen (CEA), low molecular weight cytokeratin
(CAM 5.2 antibody), desmin and vimentip, and a rabbit
polyclonal antibody to S100 were used (See Table I for
sources and positive control tissues). They were also stained
with TDM35 a murine monoclonal antibody raised against
XH1 cells (Han et al., 1990). An ABC method without
enzyme predigestion (Hsu et al., 1981) as employed using a
biotinylated anti-species secondary antibody and strept-
avidin/biotin complex (Dako, Bucks). Endogenous perox-
idase was inhibited by a sequence of hydrogen peroxide,XH1-A NEW CERVICAL CARCINOMA CELL LINE 647
Table I Antibodies used, control tissues and sources
Antibody Dilution Control tissue Source
Murine monoclonal antibodies
Epithelial membrane antigen (EMA) 1:100 2' ovarian carcinoma Dako, Bucks
Carcinoembryonic antigen (CEA) 1:5 colorectal carcinoma Amersham, Bucks Cytokeratin (CAM 5.2) 1:4 colorectal carcinoma Becton Dickinson, Oxford Vimentin 1:20 fibroid Dako, Bucks
Desmin 1:50 striated muscle Dako, Bucks
TDM35 Neat XH1 xenograft Own laboratory Rabbit polyclonal antibody
S100 1:1000 normal nerve Dako, Bucks
periodic acid, and potassium borohydride (Heyderman,
1986).
Negative controls
The relevant antigens for the antibodies used in this study
were not available to perform specificity controls using anti-
body absorbed with the corresponding antigen (Heyderman
et al., 1989). However antibodies negative on the test sections
would act as negative controls for the method and exclude
false positivity due to endogenous peroxidase or to non-
specific binding of the secondary antibodies or the ABC
complex.
Results
Morphology
Parental XHI cells have been maintained in long term cul-
ture for 26 months, and passaged over.100 times. They grow
as a flat adherent monolayer of polygonal epithelial cells,
with occasional multinucleate giant cells. Some cells contain
mucin, which is seen in small clumps in the medium just
above them. XHla cells have the same morphology in mono-
layer culture as the parental cells and grow in adherent sheets
(Figure 1), while XHlb cells grow in a diffuse fashion until
confluence (Figure 2). Some XHlb cells are flattened and
hemi-spherical, while others are more spindle shaped. Both
sublines have maintained their morphology over a further 80
passages. At EM level both XHla and XHlb cells show
occasional desmosomes and tonofilaments, confirming their
squamous origin.
The cultures have always been free from Mycoplasma
contamination.
Karyotyping
Karyotyping of XH1 cells at passage #6 showed them to be
aneuploid, with a modal chromosome number of 78, and a
Figure 2 Until confluence XHlb cells show a non-cohesive pat-
tern ofgrowth, with retention of an epithelial morphology x 165.
range of 75-86 (Figure 3). There were a number of chromo-
some rearrangements whose probable origin could be deter-
mined. These were 4p+, 5q-, lOp+, llp+, Ilp-, llq+, l2p-, 14p+, 14q+, and l5p+, and there were
several markers of unknown origin (Figure 4). The 14p +
probably contained material from 1 lq, and the 1Sp +
matenal from Sq. Three of the rearrangements were present in duplicate, which suggests that they may have originated in
a near-diploid cell which subsequently duplicated. A secon-
dary mode of 82/83 had a slightly different karyotype in
which chromosome 1 rearrangements were found. A detailed
examination is being carried out of these differences and the
karyotypes of XHla and XHlb and clones derived from
them. Full details will be reported elsewhere.
MS31 Hypervariable minisatelliteprobing
The MS31 probe showed similar bands with DNA extracted
from the patient's blood after treatment and with that from
XHI, XHla and XHlb cells. The bands were different from
HeLa (Figure 5), A431, Caski and Bowes melanoma (Figure 6). The bands from Caski and A431 ran in similar positions
to each other though that from A431 appeared to show two
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Figure 1 Uncloned XHI cells in monolayer culture showing
mainly polygonal morphology with some giant cells (large arrow)
and mucin-secreting cells (small arrow). XH1a cells have a very
similar morphology, but giant cells are less frequent x 110.
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Figure 3 Histogram showing frequency of chromosome number
per metaphase in XHI passage #6 (30 cells counted).648 X. HAN et al.
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Figure 4 Representative karyotype from XH1 passage #6 (m = marker of unknown origin).
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Figure 5 Southern blots of DNA from parental uncloned XH1,
clone XHla, clone XHlb, the patient's blood, and HeLa probed
with minisatellite hypervariable MS31 labelled with digoxigenin.
bands and Caski one band (Figure 6). DNA from XH1,
A431, Caski and Bowes melanoma was therefore challenged
with another digoxigenin-labelled probe, MS1. This showed
these three cell lines all to be of different origin (Figure 7).
Analysis ofPCRproducts and HPV hybridisation
The PCR products from each of XH1, XHla and XHlb
were approximately 450bp and exhibited the single EcoRI
Figure 6 Southern blots of DNA from parental uncloned XH1,
A431, CaSki and Bowes melanoma probed with MS31. Note the
similarity between the A431 and CaSki bands, though A431
probably has two bands and CaSki only one with this probe.
and PstI sites characterstics of HPV16 (Seedorf et al., 1985)
(Figure 8). The fact that the amplimers recognised this
sequence suggests that of the late genes at least the L1 region
is conserved in the primary culture and sublines. With
reference to the kilobase ladder DNA markers the identi-
fiable bands were 451 bp for the undigested product, 234/
217 bp for the EcoRl digest and 216/205 bp for the PstI
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Figure 7 Southern blots of DNA from parental uncloned XH1,
A431, CaSki and Bowes melanoma probed with MSI. A431 and
CaSki are clearly different from each other and from XH1 and
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Table II Xenograft production
Total Died Subcutaneous
mice unexpectedlya tumours Lung colonies
Uncloned
SCb 14 0 14/14 -
SCb + Ipc 3 0 3/3 -
SCb + IV 3 0 3/3 1/3
IV 5 2 - 0/3
Total 25 2 20/20 (100%) 1/6 (17%)
XHJa
SCb 5 1 4/4 -
SCb+IV 7 3 4/4 2/4
IV 5 4 - 1/1
Total 17 8 8/8 (100%) 3/5 (60%)
XHlbd
SCb 9 2 6/7 (86%) -
SC + IV 2 0 2/2 (100%) 0/2
Total 53 12 36/37 (97%) 4/13 (31%)
SC-subcutaneous inoculation. IP -Intraperitoneal inoculation. IV-
Intravenous inoculation. aEight mice died immediately after intra-
venous injection of XH1 cells. Four others were found dead unex-
pectedly. bAll animals inoculated subcutaneously received bilateral
injections. The results were regarded as positive ifone or both gave rise
to tumours. CAll three mice injected intraperitoneally developed intra-
abdominal xenografts. dSomeXHlb tumours had completely regressed
by the time the mouse was sacrificed.
XH1 XHla XHlb
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Figure 8 Restriction digests of PCR products. (1), (
undigested PCR product; (2) (8) and (14) digested wi
(3), (9) and (15) EcoRI; (4), (10) and (16) HaeIII; (5
(17) HincII; (6), (12) and (18) PstI; (M) Kilobase lai
markers: the identifiable marker bands are 1018, 510
344, 298, 220, 200, 154 and 142.
digest. The residual 30 bp fragment form the PstI
not visible by these methods. HPV16 probed, Sou
ted total cellular DNA from XH1, XH1a and XH
the presence of HPV16 sequences integrated mor
into the host chromosomal DNA. Preliminary rec(
experiments indicate that there are 50-100 copic
Growth characteristics
The doubling time of XHIa in monolayer culture
and of XH1b 21.6 h. In soft agar XHl cells grew i
rounded colonies. XHlb cells formed diffuse cli
loose contact between the cells. The mean color
efficiency (CFE) was 0.13% for XH1a cells and
XHlb cells.
Xenograft results (Table II)
XHI and XHJa Nodules of subcutaneous tumou
palpable 5-21 days after inoculation, and formi
1.5cm in diameter in 21-158 days. There was c(
variation in the growth rate and size of the tumour xeno-
grafts. The time the tumours took to reach 1.5 cm was
independent of the passage number, or the sex or age of the
mice.
Tumours derived from XH1 and XH1a cells showed an
adenosquamous morphology similar to that of the original
cervical carcinoma (Figures 9 and 10). Desmosomes and
-451 tonofilaments were seen at EM level (Figure 11 and 12).
-216/205 There was a variable amount of central necrosis, present
sometimes in tumours less than 1 cm in maximum diameter
as well as in some of the larger xenografts. There was focal
glandular differentiation, and as in the primary tumour,
epithelial mucin was demonstrable. The xenografts could be
passaged from one mouse to another by inoculation of fresh
fragments, and the passaged xenografts continued to show
the same morphology. In the three mice inoculated intra-
7) and (13) peritoneally and subcutaneously, tumour was seen at both
ith BamHI; sites.
i), (11) and
dder DNA XHlb xenografts
6/505, 394,
XHlb cells produced invasive tumours up to 6mm in dia-
meter within 6-8 days. Sections taken at this time showed
them to consist of small sheets of poorly differentiated
squamous carcinoma, surrounded by reactive macrophages
and chronic inflammatory cells. In the centres of the sheets aigesL was
ithem blot-
[lb showed
iomerically
onstruction
ss per cell.
was 16.2h
in compact
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ny forming
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Figure 9 H&E preparation of the original adenosquamous car-
cinoma from which the XHI cell line was derived. There is
central keratinisation and some clear cell differentiation x 200.
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Lung colonisation
Multiple small tumour deposits in the lung parenchyma were
seen in the lungs of 4/11 mice 23-50 days after intravenous
inoculation with XH1 (1/6) and XHIa cells (3/5) (Figure 13).
Elsewhere in the lungs there were small fibrous nodules and
calcified plaques in vessels that we interpret as the site of
arrest of other tumour cells that did not become established
(Figure 14). All of the mice had full histological examination
of the lungs. None of the other mice that had not received
intravenous injection of cells or with no evidence of lung
colonisation showed similar nodules. Eight other mice died
immediately following the intravenous injection ofXH1 cells,
and sections of the heart and lungs of six of them showed
that injected tumour cells had reached the right ventricle and
small pulmonary vessels, and had reaggregated into small
clumps. Intravenous inoculation of XHlb cells did not result
Figure 10 Subcutaneous XHl xenograft showing blood vessel in the formation of lung colonies.
invasion x 200.
Immunocytochemistry
The original cervical carcinoma, XH1 and XH1a pellets and
xenografts were positive in a strong but patchy fashion for
cytokeratin (Figure 15) EMA, and CEA. XH1b xenografts
and pellets showed patchy positivity for cytokeratin, EMA
(Figure 16), and vimentin, but were negative for CEA. There
was variable mainly weak co-expression of vimentin in the
tumours, with stronger focal vimentin positivity in the cell
pellets (Figure 17). The original tumour and all XH1 and
XH1a xenografts and cell pellets showed strong positivity for
TDM35 with the tumours positive mainly at the centre of
nodules (Figure 18). XHlb cell pellets and xenografts were
negative for TDM35. All of the tumours and cell pellets were
abundant desmosomes.
Figure 13 Small nodule of tumour in mouse lungs following
intravenous injection of XHla cells x 200.
Figure 12 Elsewhere in the XH1 xenograft there were numerous
tonofilaments.
the cells were seen to be degenerating and pyknotic (Figure
16). In nodules removed after 10-12 days, the tumours were
seen to have regressed completely or undergone cystic degen-
eration, with the cyst wall consisting ofloose vascular fibrous
tissue. No tumour cells could be identified on H&E or
immunostains. After 28 days no tumour was palpable and
sections of the site showed cellular connective tissue and
confirmed the absence of tumour.
Local invasion Figure 14 Intravascular endothelialised fibrous nodule in mouse
lungs following intravenous injection of XHIa cells. This prob- Many of the subcutaneous xenografts showed invasion into ably represents the site of arrest of tumour cells which failed to host muscle, blood vessels (Figure 10), and perineural spaces. become established x 200.
I
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Figure 15 XHI xenograft shows patchy immunoperoxidase posi-
tivity for cytokeratin (CAM 5.2) x 200.
Figure 16 XHlb xenograft immunostained with anti-EMA. The
tumour has begun to regress and cells at the centre are pyk-
notic x 320.
Figure 17 XHlb cell pellet showing some cells strongly positive
for vimentin x 320.
negative for S100 and desmin. Perineural spread and invasion
by xenografts into the host muscle was highlighted using
antibodies to S100 and desmin, for which the tumours were
themselves negative.
Discussion
In this paper data on the establishment and characterisation
of XH1, a new cervical carcinoma cell line derived from
Figure 18 XHI xenograft immunostained with monoclonal anti-
body TDM35. The distribution of staining is again focal x 200.
an adenosquamous carcinoma is presented. Two sublines
XH1a and XH1b were obtained and shown to be of epithe-
lial origin. XH1a has the adherent epithelial morphology of
the original primary cultures, while until confluence XHlb
grows in a dissociated fashion, with hemispherical or spindle-
shaped cells. Subclones of the cervical cell lines C4-I and
C4-II have also been shown to have different morphologies
and behaviour in vivo as well as in vitro (Auersperg, 1969;
Auersperg et al., 1989). A similar divergence into different
morphological types was produced in a murine bladder car-
cinoma cell line by changing the culture conditions (Boyer et
al., 1989).
It is important to exclude contamination of new cell lines
with HeLa or other established cell lines (Fogh et al., 1977a).
The hypervariable minisatellite probes MS1 and MS31 were
used to show that DNA from XH1 and its sublines was like
that extracted from the patient's white blood cells, and
different from DNA from A431, Caski, Bowes melanoma,
HeLa and mouse fibroblast 3T3 cells.
The karyotype of cultured tumour cells may undergo con-
siderable changes in vitro and there is some evidence of
chromosomal instability in XH1. However, since the culture
was examined quite early on at passage #6, it is likely that
many of the markers found were present in the original
tumour. XH1 has a karyotype similar to other cervical car-
cinomas with many rearranged chromosomes. The small
metacentric chromosome thought to be a 5q- is similar
to markers found in 75% of direct preparations from
primary cervical carcinomas (Atkin et al., 1990). The marker
M3 in XH1 may represent a similar rearrangement. No nor-
mal copies of chromosome 11 were found in XH1 indicating
that several rearrangements have occurred in this chromo-
some. Since the HeLa tumour suppressor gene has been
localised to the long arm ofchromosome 11 (Misra & Srivat-
san, 1989), in vivo changes at this region might result in loss
of llq sequences that could be important in tumourigenesis.
The XH1 sublines are being cloned by single cell selection
and the karyotype differences between them will be investi-
gated.
Several squamous cervical carcinoma cell lines have pre-
viously been reported. Some were derived from primary cer-
vical carcinomas, including HeLa, Cl, C4 I and II, C12, C33
I and II, OG, SiHa, SW756, SKG, SKG-1, SKG-2 and
SKG-III, Yumoto strain, HX151c, 155c, 156c and 160c (Gey
et al., 1952; Auersperg & Hawryluk, 1962; Auersperg, 1964;
Auersperg, 1969; Arata et al., 1969; Friedl et al., 1970;
Freedman et al., 1982; Nozawa et al., 1978; Ishiwata et al.,
1978; Yokita et al., 1980; Nozawa et al., 1982; Nozawa et al.,
1983; Kelland et al., 1987). Others were derived from secon-
dary deposits. These include CaSki, ME-180, MS751, HT-3,
EC50 and DoT (Sykes et al., 1970; Fogh & Trempe, 1975;
Patillo et al., 1977; Hussa et al., 1978; Porter et al., 1978).
The W12 cell line was established from a CIN 1 cervical
lesion (Stanley et al., 1989). C4 I and II were classified as652 X. HAN et al.
squamous carcinomas but showed mucin production (Auers-
perg, 1969), and the SKG-2 cell line also contained PAS-
positive diastase resistant material (Ishiwata et al., 1978).
These cell lines should therefore be reclassified as adeno-
squamous (Buckley & Fox, 1989). Although originally con-
sidered an epidermoid carcinoma, the HeLa cell line was
later shown to have been derived from a cervical adenocar-
cinoma (Jones et al., 1971).
Production of xenografts in nude mice using the cervical
carcinoma cell lines C4 I, C33, HT-3, ME-180, MS751 and
SW732 was reported in a large study, but no details of local
invasion were given, and none metastasised spontaneously
(Fogh et al., 1977b). Other subcutaneous cervical carcinoma
xenografts produced in nude mice include the SW756 (Porter
et al., 1978), SKG-1 and SKG-2 (Ishiwata et al., 1978;
Nozawa et al., 1982), and the HX15lc, HX155c, HX156c
and HX160c cell lines (Kelland et al., 1987). None of these
metastasised, and generally host invasion was not commented
upon, though stromal invasion was noted in the HX cell lines
(Kelland et al., 1987). Marked cachexia was seen in mice
bearing Yumoto xenografts and 80% of them died within 3
months, but none of the tumours metastasised. These authors
also produced Hela subcutaneous xenografts, some of which
mnetastasised spontaneously to the lungs (Yokita et al., 1980).
In an experiment on the human patient from whom the OG
cell line was derived, inoculation of both OG and HeLa into
the thigh at the time of tumour recurrence elsewhere resulted
in initial growth and then the tumours regressed (Arata et al.,
1969). Growth of a subcutaneous xenograft of W12 cells
derived at a site prepared by previous implantation of a glass
coverslip has also been described (Stanley et al., 1989). Local
invasion did not occur (Stanley, Personal communication).
The XH1 and XHIa xenografts are good models of local
invasion. XH1 and XH1a cells will colonise the lungs after
intravenous injection, but although vascular invasion was
seen, none of the subcutaneous tumours had metastasised
spontaneously. As the xenografts often threaten to ulcerate
the overlying skin when they are less than 1 cm in diameter,
experiments have to be terminated at this stage, which may
be too early for metastasis. We intend removing primary
subcutaneous xenografts when they are 0.75 cm in diameter,
by which time micrometastasis could have occurred. The
mice could then be maintained long enough for these metas-
tatic cells to become established and detectable (Ueyama et
al., 1978).
The original cervical tumour from which XHI was derived,
xenografts and cell pellets of XHI, XHIa and XHlb were
positive for EMA and low molecular weight cytokeratin
(CAM 5.2), consistent with their epithelial origin. They were
also focally positive for vimentin. Co-expression of vimentin
has been reported in a variety of epithelial neoplasms and is
no longer considered to imply mesenchymal origin (Dabbs &
Geisinger, 1988; Raymond & Leong, 1989). The primary
cervical carcinoma, XH1 and XH1a xenografts and cell
pellets were all positive for CEA and TDM35, which appears
to recognise an NCA-like/CEA-like molecule (Von Kleist,
1972; Han et al., 1990). The XHlb xenografts and pellets
were negative for CEA and for TDM35. CEA is a member of
the immunoglobulin supergene family, and thought to be
involved in cell adhesion and thereby to increase metastatic
potential (Hostetter et al., 1990). Absence of CEA and of the
antigen recognised by TDM35 may be factors militating
against continued XHlb xenograft growth. Evidence that not
all cells that arrest in the pulmonary vasculature continue to
grow was shown by the presence of fibrous focally calcified
nodules in lungs containing tumour colonies elsewhere.
There is a strong association between cervical carcinoma
and human papillomavirus (HPV) (Zur Hausen & Schneider,
1977). XH1 and its sublines contain integrated HPV16 as do
the other cervical carcinoma cell lines SiHa, CaSki, HX151c,
HX155c, HX156c and HX160c, while HeLa, ME180, MS751,
C4 I and C4 II contain HPV18 DNA. CaSki may have
integrated HPV18 as well as HPV16; C-33A and HT-3 have
neither (Yee et al., 1985; Pater et al., 1985; Spence et al.,
1988). As both XHIa and XHlb contain HPV16 DNA,
integration of HPV DNA does not explain their different
morphology or xenograft behaviour. It has been suggested
that patients whose cervical tumours evidence HPV integra-
tion have a better prognosis than those with HPV-negative
tumours (Riou et al., 1990). The patient from whom XH1
was derived died of the disease within a year of diagnosis.
The XHlb subline provides a promising model of tumour
regression and/or non-T cell mediated rejection. Possible
mechanisms to be investigated by us include expression of the
normal rather than a mutant p53 gene (Lane & Benchimol,
1990), lack of appropriate angiogenesis factors (Folkman &
Klagsbrun, 1987), absence of plasminogen activators (Lars-
son et al., 1987) or of other proteases such as collagenase IV
(Liotta et al., 1980). Nude mice are T cell but not natural
killer (NK) cell deficient and possible increased susceptibility
of XHlb cells to NK cells will also be examined (Richie,
1984).
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